TBPH Stock-Based Compensation
Theravance Biopharma Inc · Stock-Based Compensation
TBPH Stock-Based Compensation
Latest reported$19.55Mperiod ending
TBPH TTM Stock-Based Comp ($22.48M → $19.55M)
TTM stock-based compensation
High-resolution chart · PNG
TBPH stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 19,550,000 | |
| 18,103,000 | |
| 18,476,000 | |
| 19,822,000 | |
| 20,209,000 | |
| 21,041,000 | |
| 21,393,000 | |
| 21,391,000 | |
| 22,690,000 | |
| 23,579,000 | |
| 25,371,000 | |
| 26,497,000 | |
| 28,765,000 | |
| 32,210,000 | |
| 39,734,000 | |
| 49,702,000 | |
| 55,542,000 | |
| 60,774,000 | |
| 62,061,000 | |
| 45,143,000 | |
| 46,337,000 | |
| 31,396,000 | |
| 30,840,000 | |
| 54,752,000 | |
| 52,207,000 | |
| 63,506,000 | |
| 60,450,000 | |
| 48,252,000 | |
| 46,979,000 | |
| 49,535,000 | |
| 51,313,000 | |
| 57,392,000 | |
| 56,331,000 | |
| 52,874,000 | |
| 49,145,000 | |
| 41,392,000 | |
| 40,602,000 | |
| 40,108,000 | |
| 41,169,000 | |
| 42,640,000 | |
| 44,995,000 | |
| 49,754,000 | |
| 54,050,000 | |
| 56,959,000 | |
| 54,059,000 | |
| 46,159,000 | |
| 43,234,000 | |
| 33,973,000 | |
| 30,217,000 | |
| 29,661,000 | |
| 22,476,000 | |
| 22,488,000 | |
| 22,135,000 |